Suppr超能文献

糖耐量正常或受损受试者的空腹血糖过高与胰岛素分泌之间的关系。

The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.

作者信息

Abdul-Ghani Muhammad A, Matsuda Masafumi, Jani Rucha, Jenkinson Christopher P, Coletta Dawn K, Kaku Kohei, DeFronzo Ralph A

机构信息

Diabetes Division, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

出版信息

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E401-6. doi: 10.1152/ajpendo.00674.2007. Epub 2008 May 20.

Abstract

To assess the relationship between the fasting plasma glucose (FPG) concentration and insulin secretion in normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) subjects, 531 nondiabetic subjects with NGT (n = 293) and IGT (n = 238; 310 Japanese and 232 Mexican Americans) received an oral glucose tolerance test (OGTT) with measurement of plasma glucose, insulin, and C-peptide every 30 min. The insulin secretion rate was determined by plasma C-peptide deconvolution. Insulin sensitivity (Matsuda index) was measured from plasma insulin and glucose concentrations. The insulin secretion/insulin resistance (IS/IR) or disposition index was calculated as DeltaISR/DeltaG / IR. As FPG increased in NGT subjects, the IS/IR index declined exponentially over the range of FPG from 70 to 125 mg/dl. The relationship between the IS/IR index and FPG was best fit with the equation: 28.8 exp(-0.036 FPG). For every 28 mg/dl increase in FPG, the IS/IR index declined by 63%. A similar relationship between IS/IR index and FPG was observed in IGT. However, the decay constant was lower than in NGT. The IS/IR index for early-phase insulin secretion (0-30 min) was correlated with the increase in FPG in both NGT and IGT (r = -0.43, P < 0.0001 and r = -0.20, P = 0.001, respectively). However, the correlation between late-phase insulin secretion (60-120 min) and FPG was not significant. In conclusion, small increments in FPG, within the "normal" range, are associated with a marked decline in glucose-stimulated insulin secretion and the decrease in insulin secretion with increasing FPG is greater in subjects with NGT than IGT and primarily is due to a decline in early-phase insulin secretion.

摘要

为评估正常糖耐量(NGT)和糖耐量受损(IGT)受试者空腹血糖(FPG)浓度与胰岛素分泌之间的关系,531名非糖尿病的NGT受试者(n = 293)和IGT受试者(n = 238;其中310名日本人,232名墨西哥裔美国人)接受了口服葡萄糖耐量试验(OGTT),每30分钟测量一次血浆葡萄糖、胰岛素和C肽。胰岛素分泌率通过血浆C肽反卷积法测定。胰岛素敏感性(松田指数)根据血浆胰岛素和葡萄糖浓度进行测量。胰岛素分泌/胰岛素抵抗(IS/IR)或处置指数计算为ΔISR/ΔG / IR。随着NGT受试者FPG升高,在FPG 70至125 mg/dl范围内,IS/IR指数呈指数下降。IS/IR指数与FPG之间的关系最适合以下方程:28.8 exp(-0.036 FPG)。FPG每升高28 mg/dl,IS/IR指数下降63%。在IGT受试者中也观察到IS/IR指数与FPG之间存在类似关系。然而,衰减常数低于NGT受试者。早期胰岛素分泌(0 - 30分钟)的IS/IR指数在NGT和IGT受试者中均与FPG升高相关(r = -0.43,P < 0.0001和r = -0.20,P = 0.001)。然而,晚期胰岛素分泌(60 - 120分钟)与FPG之间的相关性不显著。总之,在“正常”范围内FPG的小幅升高与葡萄糖刺激的胰岛素分泌显著下降相关,且随着FPG升高胰岛素分泌的减少在NGT受试者中比IGT受试者更大,主要是由于早期胰岛素分泌下降。

相似文献

1
The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E401-6. doi: 10.1152/ajpendo.00674.2007. Epub 2008 May 20.
2
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.
3
Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
Diabetes Care. 1997 Oct;20(10):1562-8. doi: 10.2337/diacare.20.10.1562.
8
Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2613-2619. doi: 10.1210/jc.2018-00260.

引用本文的文献

1
Geniposide Mitigates Insulin Resistance and Hepatic Fibrosis via Insulin Signaling Pathway.
Int J Mol Sci. 2025 Aug 21;26(16):8079. doi: 10.3390/ijms26168079.
2
Predicting isolated impaired glucose tolerance without oral glucose tolerance test using machine learning in Chinese Han men.
Front Endocrinol (Lausanne). 2025 Apr 24;16:1514397. doi: 10.3389/fendo.2025.1514397. eCollection 2025.
5
Critical Evaluation of Indices Used to Assess β-Cell Function.
Diabetes. 2024 Mar 1;73(3):391-400. doi: 10.2337/db23-0613.
7
Bariatric surgery normalizes diabetes risk index by one month post-operation.
Acta Diabetol. 2023 Feb;60(2):265-271. doi: 10.1007/s00592-022-02002-x. Epub 2022 Nov 9.
9
β-cell Smad2 null mice have improved β-cell function and are protected from diet-induced hyperglycemia.
J Biol Chem. 2021 Nov;297(5):101235. doi: 10.1016/j.jbc.2021.101235. Epub 2021 Sep 25.
10
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus.
Pharmaceuticals (Basel). 2021 Aug 17;14(8):806. doi: 10.3390/ph14080806.

本文引用的文献

1
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.
2
What is the best predictor of future type 2 diabetes?
Diabetes Care. 2007 Jun;30(6):1544-8. doi: 10.2337/dc06-1331. Epub 2007 Mar 23.
5
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
J Clin Endocrinol Metab. 2005 Jan;90(1):493-500. doi: 10.1210/jc.2004-1133. Epub 2004 Oct 13.
6
Pathogenesis of type 2 diabetes mellitus.
Med Clin North Am. 2004 Jul;88(4):787-835, ix. doi: 10.1016/j.mcna.2004.04.013.
7
Who are more insulin resistant, people with IFG or people with IGT?
Diabetologia. 2004 Apr;47(4):758-9. doi: 10.1007/s00125-004-1339-1.
8
Loss of beta cell function as fasting glucose increases in the non-diabetic range.
Diabetologia. 2004 Jul;47(7):1157-1166. doi: 10.1007/s00125-004-1454-z. Epub 2004 Jul 13.
10
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.
Diabetologia. 2004 Jan;47(1):31-9. doi: 10.1007/s00125-003-1263-9. Epub 2003 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验